https://www.oncotypeiq.com/ja-jp 2024-11-22 daily 0.5 https://www.oncotypeiq.com/en/ja-jp 2024-07-26 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp 2025-10-21 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp 2023-02-02 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp 2023-12-12 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp 2024-06-07 daily 0.5 https://www.oncotypeiq.com/es/ja-jp 2024-06-07 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp 2023-11-20 daily 0.5 https://www.oncotypeiq.com/sv-se/ja-jp 2023-02-02 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp 2023-02-02 daily 0.5 https://www.oncotypeiq.com/en-ch/ja-jp 2023-09-27 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp 2023-05-02 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp 2023-12-12 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp 2023-10-11 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp 2024-07-26 daily 0.5 https://www.oncotypeiq.com/ja-jp/worldwide-websites 2023-03-07 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/worldwide-websites 2022-10-28 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/sv-se/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/en-ch/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/worldwide-websites 2022-10-10 daily 0.5 https://www.oncotypeiq.com/ja-jp/patient-treatment 2025-02-20 daily 0.5 https://www.oncotypeiq.com/ja-jp/contact/contact-us 2023-05-02 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/contact/contact-us 2023-04-27 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/contact/contact-us 2022-10-11 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/contact/contact-us 2022-10-11 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/sv-se/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/contact/contact-us 2022-09-22 daily 0.5 https://www.oncotypeiq.com/en-ch/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/contact/contact-us 2022-09-19 daily 0.5 https://www.oncotypeiq.com/ja-jp/announcements/press-room 2023-09-14 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/announcements/press-room 2024-08-28 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/announcements/press-room 2022-10-21 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/announcements/press-room 2023-01-13 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/announcements/press-room 2023-12-06 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/announcements/press-room 2023-01-13 daily 0.5 https://www.oncotypeiq.com/sv-se/ja-jp/announcements/press-room 2022-10-11 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/announcements/press-room 2024-02-13 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/announcements/press-room 2025-03-11 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/announcements/press-room 2022-12-13 daily 0.5 https://www.oncotypeiq.com/ja-jp/resources/downloads 2025-05-30 daily 0.5 https://www.oncotypeiq.com/ja-jp/resources/webcasts 2025-02-20 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/resources/webcasts 2024-10-11 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/resources/webcasts 2024-09-24 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/resources/webcasts 2025-05-07 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/resources/webcasts 2023-08-21 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/resources/webcasts 2022-10-11 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/resources/webcasts 2024-01-08 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/resources/webcasts 2023-12-07 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/resources/webcasts 2025-04-11 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/resources/webcasts 2022-10-17 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2024-04-09 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2023-11-20 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2022-10-14 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2023-04-11 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2023-02-01 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2023-09-14 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2024-05-01 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2025-04-23 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2025-12-11 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2023-01-09 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2023-09-14 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2023-01-09 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test 2023-01-09 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test 2024-04-19 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test 2024-09-05 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test 2023-08-11 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test 2022-10-26 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test 2022-10-26 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test 2022-10-06 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test 2022-09-30 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test 2022-10-06 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2024-04-09 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2024-10-07 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2023-03-17 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-evidence 2022-10-26 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-07-09 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-08-30 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-07-12 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2023-01-09 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-04-24 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-07-05 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-06-06 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-07-02 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2022-10-03 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-06-06 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-11-14 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-06-07 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/interpreting-the-results 2024-06-20 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2024-05-01 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2024-01-31 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2022-10-12 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2023-02-01 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2022-09-09 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2022-10-20 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2022-09-13 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2022-09-16 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2022-09-02 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2022-09-01 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-positive-clinical-value 2022-10-14 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2024-04-11 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2024-09-19 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2023-04-11 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2024-02-07 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2023-12-14 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-evidence 2022-10-14 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2024-04-11 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2024-01-24 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2023-04-14 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2024-04-15 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2023-04-14 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2023-04-14 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2023-04-14 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2023-04-14 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2023-04-14 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2023-12-14 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/node-negative-clinical-value 2023-04-14 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2024-04-11 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2024-12-23 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2022-09-18 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2022-09-09 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2022-10-27 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2022-09-16 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2022-10-14 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2022-10-13 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2022-10-17 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2022-09-12 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/prognostic-vs-predictive 2022-11-02 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/whom-to-test 2024-04-09 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/whom-to-test 2024-10-30 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/whom-to-test 2022-10-14 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/whom-to-test 2022-10-14 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/whom-to-test 2022-10-14 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/whom-to-test 2022-10-14 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/whom-to-test 2022-10-14 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/whom-to-test 2022-10-14 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/whom-to-test 2022-10-14 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/patient-information 2023-12-12 never 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2023-04-20 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2023-05-02 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2023-05-02 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/about-the-test 2022-10-18 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2023-04-11 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2023-05-02 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2023-05-02 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/eligibility-and-testing 2022-10-18 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2023-04-05 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-28 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-20 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-07 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-09-26 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-20 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-18 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-20 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-17 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-20 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-20 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-09-26 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/oncotype-dx-results-what-to-expect 2022-10-20 daily 0.5 https://www.oncotypeiq.com/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2023-04-16 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/es-es/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2023-11-13 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/faqs-and-useful-resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/impressum 2022-10-13 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/case-study-submission 2022-10-12 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/customer-step-by-step-ordering-to-results-guide-exact-sciences 2024-06-11 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/customer-step-by-step-ordering-to-results-guide-exact-sciences 2024-06-11 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/confidence-in-treatment-decisions-change-licata-et-al-breast-cancer 2024-02-23 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-self-exam 2024-10-21 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-self-exam 2024-10-23 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/nice-diagnostics-guidance-early-stage-breast-cancer 2024-10-14 daily 0.5 https://www.oncotypeiq.com/en-ch/ja-jp/about/reimbursement 2022-10-17 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/contact/nordics 2024-07-25 never 0.5 https://www.oncotypeiq.com/en/ja-jp/announcements/aiom-2024 2024-11-06 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/announcements/ebcc 2024-03-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/announcements/esmo 2024-09-10 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/announcements/esmo-2024 2024-09-03 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/announcements/rxponder 2022-10-19 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/announcements/rxponder 2022-10-19 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/announcements/sabcs 2022-10-28 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/announcements/sabcs 2022-12-02 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/announcements/st-gallen 2023-03-08 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/announcements/tailorx 2023-09-27 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/announcements/tailorx 2022-11-10 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/announcements/tailorx 2022-10-18 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/announcements/tailorx 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/announcements/tailorx 2022-11-10 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/announcements/tailorx 2022-10-18 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/resources/virtueller-stand 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/is-your-patient-eligible 2022-10-14 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/ordering 2022-10-18 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/ordering 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies 2023-01-06 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies 2023-02-02 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies 2023-02-02 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies 2023-02-02 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies 2023-02-02 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies 2023-02-02 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies 2023-02-02 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/clinical-trials 2022-10-06 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/clinical-trials 2023-11-08 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-can-i-access-reports 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/insurance-coverage-and-financial-assistance 2022-10-28 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/insurance-coverage-and-financial-assistance 2022-10-19 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/insurance-coverage-and-financial-assistance 2022-10-14 daily 0.5 https://www.oncotypeiq.com/en-ie/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/publications 2023-05-02 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/quantitative-single-gene-scores 2022-10-18 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/reading-the-reports 2022-10-13 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/reading-the-reports 2024-11-12 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/patient-profile-navigator-italy 2024-10-31 never 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/patient-profile-navigator-italy 2023-04-24 never 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/recurrence-score 2022-10-18 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/recurrence-score 2022-10-18 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/resources 2022-10-18 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/underlying-technology 2022-10-17 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/what-do-major-guidelines-say 2022-09-28 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/what-do-major-guidelines-say 2022-10-17 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/what-steps-are-necessary 2022-10-12 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/which-patients 2022-10-18 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/clinical-trials 2022-10-17 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/how-was-the-test-developed 2022-09-27 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/how-was-the-test-developed 2022-10-06 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/when-should-the-test-be-used 2022-10-06 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/when-should-the-test-be-used 2022-10-17 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/getting-tested 2022-10-17 daily 0.5 https://www.oncotypeiq.com/en-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/hear-from-our-patients 2022-10-18 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/hear-from-our-patients 2022-10-18 daily 0.5 https://www.oncotypeiq.com/fr-ca/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/hear-from-our-patients 2022-10-18 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/hear-from-our-patients 2022-10-18 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/insurance-coverage-and-financial-assistance 2022-10-18 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/news 2022-10-04 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/news 2022-10-04 daily 0.5 https://www.oncotypeiq.com/el-gr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/news 2022-10-17 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/news 2022-10-04 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/news 2022-10-11 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/patients-and-caregivers/stage-i-iiia-invasive/news 2022-10-12 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/29-1-24 2022-09-20 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/29-1-24 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/29-1-24 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/29-1-24 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/29-1-24 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/29-1-24 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/29-1-24 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/35-1-16 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/35-1-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/35-1-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/35-1-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/35-1-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/35-1-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/35-1-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/37-0-11 2022-08-17 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/37-0-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/37-0-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/37-0-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/37-0-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/37-0-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/37-0-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-1-14 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-2-12 2022-09-12 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/38-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-13 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-9 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-29 2022-09-16 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/39-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-15 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-26 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-5-17 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-5-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-5-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-5-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-5-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-5-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-5-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-9-10 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-9-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-9-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-9-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-9-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-9-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/40-9-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-29 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-32 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-32 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-32 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-32 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-32 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-32 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/41-2-32 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/42-2-19 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/42-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/42-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/42-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/42-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/42-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/42-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-13 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-18 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/43-3-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-5 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-5 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-5 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-5 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-5 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-5 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-5 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-6 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-2-14 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-2-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-2-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-2-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-2-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-2-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/45-2-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-0-14 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-12 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-13 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-2-18 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/46-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/47-2-12 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/47-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/47-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/47-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/47-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/47-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/47-2-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/48-2-8 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/48-2-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/48-2-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/48-2-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/48-2-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/48-2-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/48-2-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/49-7-9 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/49-7-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/49-7-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/49-7-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/49-7-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/49-7-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/49-7-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-1-6 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-1-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-20 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-7 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-2-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-7-15 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-7-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-7-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-7-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-7-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-7-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/50-7-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-0-30 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-0-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-0-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-0-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-0-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-0-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-0-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-1-8 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-1-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-1-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-1-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-1-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-1-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-1-8 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-19 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-55 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-55 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-55 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-55 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-55 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-55 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/51-2-55 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-0-14 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-0-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-3-61 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-3-61 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-3-61 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-3-61 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-3-61 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-3-61 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-3-61 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-4-28 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-4-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-4-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-4-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-4-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-4-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/52-4-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-10 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-13 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/53-1-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-20 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-2-0 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-2-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-2-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-2-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-2-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-2-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-2-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-6-13 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-6-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-6-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-6-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-6-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-6-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/54-6-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-27 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-48 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-48 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-48 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-48 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-48 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-48 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/55-2-48 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-1-43 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-1-43 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-1-43 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-1-43 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-1-43 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-1-43 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-1-43 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-2-19 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/56-2-19 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-18 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-21 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-21 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-21 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-21 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-21 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-21 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-0-21 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-1-27 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-1-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-1-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-1-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-1-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-1-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/57-1-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-3-11 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-3-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-3-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-3-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-3-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-3-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-3-11 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-4-6 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-4-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-4-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-4-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-4-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-4-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/58-4-6 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-0-7 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-0-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-0-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-0-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-0-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-0-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-0-7 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-1-14 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/59-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-0-28 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-0-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-0-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-0-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-0-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-0-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-0-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-25 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-25 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-25 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-25 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-25 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-25 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-25 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-28 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/60-1-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28-2 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28-2 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28-2 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28-2 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28-2 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28-2 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/61-1-28-2 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/62-1-10 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/62-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/62-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/62-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/62-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/62-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/62-1-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-17 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-17 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-27 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-29 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-34 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-3-28 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-3-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-3-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-3-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-3-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-3-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/63-3-28 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-1-41 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-1-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-1-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-1-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-1-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-1-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-1-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-3-33 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-3-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-3-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-3-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-3-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-3-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-3-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-4-13 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-4-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-4-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-4-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-4-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-4-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/64-4-13 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/65-8-18 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/65-8-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/65-8-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/65-8-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/65-8-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/65-8-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/65-8-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-15 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-9 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/66-0-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/67-1-15 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/67-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/67-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/67-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/67-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/67-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/67-1-15 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-0-22 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-0-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-0-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-0-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-0-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-0-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-0-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-20 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-20 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-27 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-34 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-34 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-45 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/68-2-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-12 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-12 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-46 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-46 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-46 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-46 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-46 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-46 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-1-46 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-3-27 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/69-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-0-23 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-0-23 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-0-23 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-0-23 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-0-23 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-0-23 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-0-23 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-10 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-18 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-18 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-26 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-31 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-31 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-31 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-31 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-31 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-31 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/70-2-31 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-33 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-33 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-37 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-1-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-2-30 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-2-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-2-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-2-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-2-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-2-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-2-30 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-3-37 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-3-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-3-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-3-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-3-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-3-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-3-37 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-4-10 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-4-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-4-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-4-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-4-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-4-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/71-4-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-0 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-0 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-45 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/72-1-45 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-1-14 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-1-14 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-10 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-10 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-16 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/73-2-16 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-26 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-58 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-58 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-58 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-58 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-58 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-58 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-58 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-9 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-1-9 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-2-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-2-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-2-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-2-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-2-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-2-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/74-2-22 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-0-26 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-0-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-0-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-0-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-0-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-0-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-0-26 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-3-51 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-3-51 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-3-51 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-3-51 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-3-51 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-3-51 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/76-3-51 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-27 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-41 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-0-41 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-3-27 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/77-3-27 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/86-2-29 2022-08-25 daily 0.5 https://www.oncotypeiq.com/de-de/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/86-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/es/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/86-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/pt-br/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/86-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/nl-nl/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/86-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/en-gb/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/86-2-29 2022-09-15 daily 0.5 https://www.oncotypeiq.com/fr-fr/ja-jp/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/case-studies/86-2-29 2022-09-15 daily 0.5